Home
Conditions
Skin and Connective Tissue Diseases

Clinical trial condition

Skin and Connective Tissue Diseases

Explore clinical trials studying Skin and Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

28,259 public trials 4,410 recruiting studies

Refine in advanced search Browse all conditions

Skin and Connective Tissue Diseases trial results

Recruiting

Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome

NCT05789056

Conditions: Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Site #1 San Diego, California, United States

Site #4 Indianapolis, Indiana, United States

Site #5 Quincy, Massachusetts, United States

Site #2 San Antonio, Texas, United States

View Trial Details

Recruiting

NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care

NCT07424261

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Fatigue, +5 more
Locations: Research Site Altenburg, Germany

Research Site Bad Bramstedt, Germany

Research Site Berlin, Germany

Research Site Chemnitz, Germany

View all 19 locations

View Trial Details

Recruiting

A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

NCT06075810

Conditions: Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +6 more
Locations: Precision Next Gen Oncology & Research Center Beverly Hills, California, United States

Florida Cancer Specialists / Sarah Cannon Research Institute / SCRI Sarasota, Florida, United States

Sarah Cannon Research Institute/SCRI Nashville, Tennessee, United States

FDI Clinical Research San Juan, Puerto Rico

View Trial Details

Recruiting

Study of 18F-FFNP Breast PET/MRI

NCT06086704

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: UW Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Recruiting

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

NCT05896839

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +34 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Keck Medicine of USC Koreatown Los Angeles, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View all 26 locations

View Trial Details

Recruiting

Pilot SMART of a Remotely Delivered, Physical Activity Intervention for Breast Cancer Survivors

NCT07706556

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Dartmouth-Hitchcock Clinic Lebanon, New Hampshire, United States

View Trial Details

Recruiting

Disease Activity Monitoring in Patients With Giant Cell Arteritis Study

NCT07552636

Conditions: Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more
Locations: Aalborg University Hospital, Department of Rheumatology Aalborg, Denmark

Aarhus University Hospital, Department of Rheumatology Aarhus, Denmark

Rigshospitalet Glostrup, Center for Rheumatology and Spine Diseases Rigshospitalet Glostrup Municipality, Denmark

Regional Hospital Horsens, Department of Medicine Horsens, Denmark

View Trial Details

Recruiting

A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults

NCT07749651

Conditions: Connective Tissue Diseases, Cutaneous Lupus Erythematosus(CLE), Lupus Erythematosus, Cutaneous, +2 more
Locations: Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts

NCT03977753

Conditions: Common Wart, DNA Virus Infections, Flat Wart, +10 more
Locations: Clinique Saint-Luc (Bouge) Bouge, Belgium

Private Practice Ghent, Belgium

Private Practice Oisquercq, Belgium

Private Practice Saint-Symphorien, Belgium

View Trial Details

Recruiting

Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN

NCT06690827

Conditions: AML (Acute Myeloid Leukemia), BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm), Blastic Plasmacytoid Dendritic Cell Neoplasm, +14 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology. Wuhan, Hubei, China

View Trial Details

Skin and Connective Tissue Diseases

Skin and Connective Tissue Diseases trial results

Related conditions